Showing results (101-110 of 108) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Neurology|November 26, 2013
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of NeurologyRobert G Miller, Benjamin Rix Brooks, Rebecca J Swain-Eng, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2012
Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: a study in a large French cohortMaya Abdelnour-Mallet, Sophie Tezenas Du Montcel, Pamela A Cazzolli, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.Basic and Clinical Andrology|November 7, 2018
Male reproductive health statement (XIIIth international symposium on Spermatology, may 9th-12th 2018, Stockholm, SwedenHagai Levine, Hideo Mohri, Anders Ekbom, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.Neurology|March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trialsLeonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.Plos One|May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trialVincent Meininger, Pierre-François Pradat, Andrea Corse, et al.Muscle & Nerve|January 9, 2019
Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosisGary L Pattee, Emily K Plowman, Kendrea L Focht Garand, et al.Pageof 11